8-K/A: Co-Diagnostics Secures $3.1M Loan with Dilutive ATM Financing

Co-Diagnostics, Inc. has entered into a $3.1 million loan agreement with J.J. Astor & Co., secured by a senior-priority lien on company assets and tied to its at-the-market (ATM) financing program.

Summary

• Co-Diagnostics, Inc. has entered into a Loan Agreement with J.J. Astor & Co. for up to $3.1 million in two tranches.
• The initial loan is $2.1 million, with an additional $1.0 million available 60 days later.
• The loans are evidenced by senior secured installment promissory notes with original principal amounts reflecting a 1.35x factor rate ($2.835M for the initial loan, $1.35M for the additional loan).
• A 4% origination fee was retained by the lender from the initial funded amount, resulting in net proceeds of approximately $2.016 million.
• The company must maintain a minimum cash balance of $250,000 while the notes are outstanding.
• Proceeds are intended for general working capital.
• The notes are secured by a senior-priority lien on substantially all company assets and guaranteed by subsidiaries.
• The company issued 600,000 commitment shares to the lender, subject to a make-whole provision.
• The agreement involves an ATM Waterfall Distribution, where 100% of net ATM proceeds are remitted to a controlled account for distribution to the lender and the company based on a specific waterfall.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative development due to the significant dilution and unfavorable terms of the financing, despite the immediate need for capital.

Positives

• Secures immediate funding of $2.1 million to support general working capital.
• Provides an option for an additional $1.0 million in funding.
• The loan is secured by company assets, which may be preferable to unsecured debt.
• The company has the option to prepay the notes without penalty.

Negatives

• The effective interest rate is significantly higher due to the 1.35x factor rate on the principal amount and the 4% origination fee.
• The company issued 600,000 commitment shares to the lender, representing potential dilution.
• The ATM Waterfall Distribution agreement dictates that 100% of net ATM proceeds will be remitted to a controlled account, with a significant portion allocated to the lender before the company receives any excess.
• The lender has the right to convert the loan into common stock at a discount (90% of VWAP, subject to a floor price), leading to substantial dilution.
• Upon an event of default, the outstanding balance increases by 20% and accrues default interest at 19% per annum.
• The company must seek stockholder approval for issuances exceeding Nasdaq limitations, which could be a hurdle.
• The company is required to maintain a minimum cash balance of $250,000.

Risks

• Significant dilution risk for existing shareholders due to the lender's conversion rights into common stock at a discounted price.
• The ATM Waterfall Distribution mechanism heavily favors the lender, potentially leaving the company with minimal cash flow from its ATM program until the notes are repaid.
• The potential for an Event of Default, which would accelerate the debt, increase the principal amount by 20%, and impose a high default interest rate.
• The company's ability to meet its obligations is contingent on its ATM financing program, which is subject to market conditions and Nasdaq listing rules.
• The requirement to maintain a minimum cash balance of $250,000 could strain liquidity.
• The lender's ability to convert debt to equity at a price significantly below market value poses a substantial risk to existing shareholders.

Future Outlook

The company intends to use the net proceeds for general working capital purposes. The company must also seek stockholder approval for issuances exceeding Nasdaq limitations and file a preliminary proxy statement within five business days after funding, mail the definitive proxy statement within five business days after SEC clearance, and hold the stockholder meeting within 30 days after mailing.

Management Comments

• The Company intends to use the net proceeds for general working capital purposes.
• The Company and the Lender entered into an ATM Waterfall Distribution Agreement.
• The Company and Maxim also entered into an ATM Payment Direction Letter.
• The Loan Agreement contains customary representations, warranties, affirmative and negative covenants and events of default.
• The Company and the Lender also entered into a registration rights agreement.

Industry Context

StockSavvy.ai notes that this type of financing, often referred to as a 'loan and ATM' or 'convertible debt with ATM' structure, is common for companies needing capital but facing challenges accessing traditional financing or seeking to avoid immediate significant dilution from a direct equity offering. However, the terms here, particularly the waterfall distribution and conversion discounts, appear highly unfavorable and indicative of distress or a very challenging capital market environment for the company.

Comparison to Industry Standards

• Traditional secured loans typically have interest rates based on benchmarks like SOFR plus a spread, not a factor rate applied to the principal amount.
• Convertible debt conversion prices are usually set at a premium to the current market price or a smaller discount (e.g., 5-10%) rather than 90% of VWAP with a potentially very low floor price.
• The 100% remittance of ATM proceeds to a lender-controlled account until debt is satisfied is an extreme measure, far beyond typical security arrangements.
• Origination fees for such loans are generally lower than 4%, especially when combined with other fees and warrants/commitment shares.
• Companies like Sorrento Therapeutics (SRNE) have utilized similar convertible notes with warrants and ATM facilities, but the specific waterfall and conversion terms in this filing are notably aggressive.
• The structure resembles some distressed debt financing scenarios where lenders demand significant concessions and control over future cash flows and equity.

Related Party Transactions

• The agreement is between Co-Diagnostics, Inc. and J.J. Astor & Co., where J.J. Astor & Co. is the Lender.
• Maxim Group LLC acts as the ATM Sales Agent and placement agent.

Stakeholder Impact

• Shareholders face significant dilution risk due to the lender's conversion rights and the deep discount at which conversion can occur.
• The company's ability to access its own ATM proceeds is severely restricted, impacting operational flexibility and working capital management.
• Creditors may be concerned about the senior-priority lien on substantially all company assets granted to J.J. Astor & Co.
• Subsidiaries acting as guarantors are exposed to the company's liabilities under the loan agreement.

Next Steps

• The company must execute the Deposit Account Control Agreement (DACA) by October 15, 2026.
• The company may elect to borrow the additional $1.0 million loan 60 days after the Agreement Date.
• The company must file a preliminary proxy statement within five business days after funding of the Initial Loan.
• The company must mail the definitive proxy statement within five business days after SEC clearance.
• The company must hold the stockholder meeting within 30 days after mailing the definitive proxy statement.
• The company must file a registration statement with the SEC within 30 days from the funding date of the Initial Loan to register shares for resale by the Lender.
• The registration statement must become effective within 60 days of the funding date of the Initial Loan.

Key Dates

Recommendation

The terms of the financing are highly unfavorable, indicating potential financial distress. The significant dilution from convertible notes with aggressive discount provisions, coupled with the restrictive ATM waterfall distribution that prioritizes lender repayment over company access to its own capital, presents substantial risks to existing shareholders. The effective cost of capital is extremely high, and the covenants and default provisions are punitive. This structure suggests the company has limited alternative financing options and is likely to experience further financial pressure.

Keywords

Loan Agreement, ATM Financing, Waterfall Distribution, Convertible Promissory Note, Secured Debt, Dilution, Working Capital, J.J. Astor & Co.